With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging ...
VMPL New Delhi [India] November 7 Medtronic a global leader in healthcare technology unveiled results from the Prospective ...
A new medical technology fund which focusses on early-stage health technologies is itself an innovation. Utilizing its ...
J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing rapid adoption.
The rapidly growing aging population is driving expansion in healthcare, with rising demand for treatments and chronic disease management. Companies like AbbVie (ABBV), Medtronic (MDT), and Centene ...
Zacks.com on MSN5d
Medtronic Stock Trading at a Discount Before Q2 Earnings: Time to Buy?Medtronic plc MDT is scheduled to report second-quarter fiscal 2025 results on Nov. 19, before the opening bell. In the last reported quarter, the company’s adjusted earnings of $1.23 exceeded the ...
November 13, 2024--(BUSINESS WIRE)--Lumicell, Inc., a privately held company focused on developing innovative ...
This growth is primarily driven by the rising prevalence of cardiovascular diseases (CVDs) worldwide, alongside continuous ...
This article explores practical use cases for AR/VR, highlighting how these technologies are revolutionizing workflows, ...
Boston Scientific faces intense competition from J&J, Medtronic, and Abbott Laboratories ... Boston Scientific endured ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback